Office-Based Labs (OBL) Corner: Features

OBL Corner

OBL Spotlight: Advanced Heart & Vascular Institute of Hunterdon

10/31/2024

Vascular Disease Management recently spoke with interventional cardiologist Andrey Espinoza, MD, about this office-based lab (OBL) in Flemington, New Jersey.

Vascular Disease Management...

10/31/2024

Vascular Disease Management

AMP 2024

OEIS National Registry: An Update on CLI Patients and Complications

09/18/2024

Watch as Dr. Bret Wiechmann discusses his AMP 2024 presentation on the latest updates to the OEIS Registry.

Watch as Dr. Bret Wiechmann...

09/18/2024

Vascular Disease Management

AMP 2024

How to Manage Complex CLI Patients With Wounds in an Outpatient Program

08/14/2024

At Wednesday’s session on CLI in 2024, Laiq Raja, MD, FACC, FSCAI, from El Paso Cardiology Associates in El Paso, Texas, presented on the effective management of complex critical limb ischemia (CLI) patients with wounds in an outpatient...

At Wednesday’s session on CLI in...

08/14/2024

Vascular Disease Management

Interview

Starting an OBL From Scratch

03/13/2024

Michelle Maneevese, MD
Access Vascular Health, Houston, Texas

Michelle Maneevese, MD Access Vascula...

As part of an Early Career Session at ISET 2024, Michelle Maneevese, MD, presented “Starting an OBL from Scratch,” an overview of how she opened her office-based lab (OBL), and gave advice for those thinking of starting their own OBL.

As part of an Early Career...

03/13/2024

Vascular Disease Management

Commentary

What Not To Do in an Office-Based Lab

03/08/2024

Moiz Shah, MD¹; John Blebea MD, MBA²

¹National Registry, Outpatient Endovascular and Interventional Society, Chicago, Illinois;²Department of Surgery, College of Medicine, Central Michigan University, Saginaw, Michigan

Moiz Shah, MD1; John Blebea MD, MBA21...

Careful selection of which cases not to take is an effective way of avoiding complications in an OBL. Determining what cases to avoid is largely dependent on 4 major variables: the physician, the patient, the procedure, and the OBL itself.

Careful selection of which cases...

03/08/2024

Vascular Disease Management

AMP 2023

Benefits of Running an Office-Based Lab

11/15/2023

Laiq Raja , MD, FACC, FSCAI;

In this video, Interventional Cardiologist Dr. Laiq Raja discusses the benefits of an office-based lab, for both physicians and patients.

In this video, Interventional...

11/15/2023

Vascular Disease Management

AMP 2023

Inspiration to Open an Office-Based Lab

11/15/2023

Chris LeSar , MD, FACS, RVT;

Dr. Chris LeSar talks about the driving forces that led him to open his own office-based lab.

Dr. Chris LeSar talks about the...

11/15/2023

Vascular Disease Management

Podcast

Using Atherectomy to Treat CLI and Why OBLs Are Needed

10/18/2023

In this episode of Vascular Voices, join Drs. Bret Wiechmann, Thomas Davis, and Eric Secemsky as they discuss the current debate about using atherectomy to treat patients with critical limb ischemia and why office-based labs are needed in the...

In this episode of Vascular...

10/18/2023

Vascular Disease Management

AMP 2023

Why the OBL/ASC Is Critical in the Treatment of the CLI Patient

08/21/2023

Bret N. Wiechmann , MD, FSIR, FAHA;

Interventional radiologist Dr Bret Wiechmann presented a discussion about the importance of office-based labs and ambulatory surgery centers when treating patients with critical limb ischemia.

Interventional radiologist Dr...

08/21/2023

Vascular Disease Management

Commentary

OEIS Response to Recent Media Articles Regarding Outpatient Vascular Care

08/02/2023

OEIS Executive Committee

One-sided stories do not tell the whole story of the CLI/CLTI epidemic and omit the vast, overwhelming majority of patients who successfully undergo limb salvage/preservation. OEIS believes the better story is one that educates the public...

One-sided stories do not tell...

08/02/2023

Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

First Aid guidelines

AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies

11/14/2024

These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.

These are the first major...

11/14/2024

Cath Lab Digest

Late-Breaking Trials

Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/06/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...

The VIVA Foundation, a...

11/06/2024

Vascular Disease Management

Late-Breaking Trials

Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/05/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/05/2024

Vascular Disease Management

Late-Breaking Trials

Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/04/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/04/2024

Vascular Disease Management

Late-Breaking Trials

First Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/04/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/04/2024

Vascular Disease Management

Image-Guided Therapy

Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease

11/04/2024

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...

With a unique world-first...

11/04/2024

Vascular Disease Management

Pulmonary Embolism

Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism

11/04/2024

QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...

QUADRA-PE study will evaluate...

11/04/2024

Vascular Disease Management

Peripheral Arterial Disease

FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease

11/04/2024

MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...

MOUNTAIN VIEW, Calif. – November...

11/04/2024

Vascular Disease Management

Patient Awareness

Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases

10/31/2024

New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...

New survey reveals nearly one in...

10/31/2024

Vascular Disease Management

DCB

SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery

10/30/2024

Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...

Data from the prospective,...

10/30/2024

Cath Lab Digest

Office-Based Labs (OBL) Corner: Features

Stay in the Know

News

Specialties

Events

Year Round Education

HMP Global Products